Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-14 |
2024-03 |
-7.6 |
-1.31 |
6.29 |
82.76% |
2024-04-04 |
2023-12 |
-5.56 |
N/A |
N/A |
N/A |
2023-11-14 |
2023-09 |
-24.32 |
-4.88 |
19.44 |
79.93% |
2023-11-14 |
2023-09 |
-24.32 |
N/A |
N/A |
N/A |
2023-08-14 |
2023-06 |
-12 |
-13.52 |
-1.52 |
-12.67% |
2023-08-14 |
2023-06 |
-12 |
N/A |
N/A |
N/A |
Date |
Name |
Relation |
Quantity |
Description |
2016-07-05 |
AFH HOLDING & ADVISORY L L C |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Stock Award(Grant) |
2015-12-30 |
BOOTH JOHN J |
Director |
40.82K |
Stock Gift |
2015-12-27 |
COFFIN WILLIAM F |
Director |
40.82K |
Stock Award(Grant) |
2015-12-27 |
DELSHAD JIMMY |
Director |
40.82K |
Stock Award(Grant) |
2023-09-10 |
FRELICK JEFFREY |
Chief Executive Officer |
17.20K |
Purchase |
2020-01-01 |
HANKEY BRET CONRAD |
Director |
0.00 |
Purchase |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Walleye Capital LLC |
295.00K |
421.85K |
9.41% |
2023-06-29 |
Kepos Capital Lp |
50.00K |
71.50K |
1.60% |
2023-06-29 |
Warberg Asset Management LLC |
27.00K |
38.61K |
0.86% |
2023-06-29 |
Virtu Financial LLC |
15.93K |
22.78K |
0.51% |
2023-06-29 |
Sabby Management, LLC |
10.82K |
15.47K |
0.35% |
2023-06-29 |
Tower Research Capital LLC (TRC) |
6.04K |
8.64K |
0.19% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
197.00 |
1.00K |
0.01% |
Split |
Date |
1 : 8 |
2023-12-20 |
1 : 30 |
2023-06-07 |
1 : 2 |
2021-10-13 |
1 : 10 |
2018-07-24 |